Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors

被引:4
|
作者
Marquez-Gonzalez, Horacio [1 ]
Mendez-Galvan, Jorge F. [2 ]
Reyes-Lopez, Alfonso [3 ]
Klunder-Klunder, Miguel [4 ]
Jimenez-Juarez, Rodolfo [5 ]
Garduno-Espinosa, Juan [6 ]
Solorzano-Santos, Fortino [7 ]
机构
[1] Hosp Infantii Mexico Federico Gomez, Dept Clin Res, Mexico City, DF, Mexico
[2] Hosp Infantil Mexico Dr Federico Gomez, Ctr Res Emerging Dis, Mexico City, DF, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Ctr Hlth Econ, Mexico City, DF, Mexico
[4] Hosp Infantil Mexico Dr Federico Gomez, Res Management, Mexico City, DF, Mexico
[5] Hosp Infantil Mexico Dr Federico Gomez, Clin Infect Dis Dept, Mexico City, DF, Mexico
[6] Hosp Infantil Mexico Dr Federico Gomez, Clin Res Direct, Mexico City, DF, Mexico
[7] Hosp Infantil Mexico Federico GomezMexico Federic, Infect Dis Res Dept, Mexico City, DF, Mexico
关键词
Mexico; SARS-CoV-2; survival analysis; cohort study; comorbidity; COVID-19; outbreak; CLINICAL CHARACTERISTICS; SARS-COV-2; INFECTION; COVID-19; COMORBIDITIES;
D O I
10.3389/fpubh.2021.660114
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The pandemic caused by the new coronavirus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries. The most lethal clinical presentation is respiratory insufficiency, requiring attention in intensive care units (ICU). The most susceptible people are over 60 years old with comorbidities. The health systems organization may represent a transcendental role in survival. Objective: To analyze the correlation of sociodemographic factors, comorbidities and health system organization variables with survival in cases infected by SARS-CoV-2 during the first 7 months of the pandemic in Mexico. Methods: The cohort study was performed in a health system public basis from March 1st to September 30th, 2020. The included subjects were positive for the SARS-CoV-2 test, and the target variable was mortality in 60 days. The risk variables studied were: age, sex, geographic distribution, comorbidities, health system, hospitalization, and access to ICU. Bivariate statistics (X-2-test), calculation of fatality rates, survival analyses and adjustment of confusing variables with Cox proportional-hazards were performed. Results: A total of 753,090 subjects were analyzed, of which the 52% were men. There were 78,492 deaths (10.3% of general fatality and 43% inpatient). The variables associated with a higher risk of hospital mortality were age (from 60 years onwards), care in public sectors, geographic areas with higher numbers of infection and endotracheal intubation without management in the ICU. Conclusions: The variables associated with a lower survival in cases affected by SARS-CoV-2 were age, comorbidities, and respiratory insufficiency (with endotracheal intubation without care in the ICU). Additionally, an interaction was observed between the geographic location and health sector where they were treated.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Anxiety and Related Factors in Parents About Coronavirus Disease-2019 for Children
    Yaz, Seyda Binay
    Kahraman, Ayse
    Gumus, Merve
    [J]. JOURNAL OF PEDIATRIC RESEARCH, 2022, 9 (01) : 5 - 13
  • [22] Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019
    Fishkin, Tzvi
    Goldberg, Michael D.
    Frishman, William H.
    [J]. CARDIOLOGY IN REVIEW, 2021, 29 (06) : 292 - 295
  • [23] Pott's puffy tumor in coronavirus disease-2019 associated mucormycosis
    Arora, Ripu Daman
    Thangaraju, Pugazhenthan
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2022, 55
  • [24] Assessment of Risk Factors for Coronavirus Disease-2019 in Healthcare Workers: A Case-Control Study
    Kerai, Sukhyanti
    Singh, Rahil
    Saxena, Kirti N.
    Desai, Suraj D.
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (01) : 76 - 84
  • [25] Gender differences in treatment of Coronavirus Disease-2019
    Ambrosino, Immacolata
    Barbagelata, Elena
    Corbi, Graziamaria
    Ciarambino, Tiziana
    Politi, Cecilia
    Moretti, Anna Maria
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (04) : 646 - 656
  • [26] Coronavirus disease-2019 and the intestinal tract: An overview
    Alberca, Gabriela Gama Freire
    Solis-Castro, Rosa Liliana
    Solis-Castro, Maria Edith
    Alberca, Ricardo Wesley
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (13) : 1255 - 1266
  • [27] Impact of Coronavirus Disease-2019 on Participants in Deliver
    Bhatt, Ankeet
    Kosiborod, Mikhail N.
    Claggett, Brian
    Miao, Zi
    Vaduganathan, Muthiah
    Lam, Carolyn S.
    Hernandez, Adrian F.
    Martinez, Felipe
    Inzucchi, Silvio E.
    Shah, Sanjiv J.
    De Boer, Rudolf A.
    Jhund, Pardeep S.
    Desai, Akshay S.
    Fang, James C.
    Comin-Colet, Josep
    Drozdz, Jaroslaw
    Vardeny, Orly
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J.
    Solomon, Scott
    [J]. CIRCULATION, 2022, 146 (25) : E594 - E594
  • [28] Cremation Challenge Under Coronavirus Disease-2019
    Au, Sunny Chi Lik
    [J]. EUROPEAN JOURNAL OF GERIATRICS AND GERONTOLOGY, 2021, 3 (01): : 29 - 31
  • [29] Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
    Bernstein, Henry H.
    McNally, Veronica Valentine
    Orenstein, Walter A.
    [J]. JOURNAL OF PEDIATRICS, 2022, 242 : 235 - 237
  • [30] Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
    Li Huang
    Zhang, Che
    Zhou, Xihui
    Zhao, Zhou
    Wang, Weiping
    Leng, Weidong
    Su, Xiao
    Lian, Qizhou
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)